Dott.ssa Sara Paola Albasini
Attività di ricerca: SeniorPubblicazioni
- Ultrastructural analysis of breast cancer patient-derived organoids Lorena Signati, Raffaele Allevi, Francesca Piccotti, Sara Albasini, Laura Villani, Marta Sevieri, Arianna Bonizzi, Fabio Corsi, Serena Mazzucchelli. Cancer Cell Int. 2021 Aug 10;21(1):423. doi: 10.1186/s12935-021-02135-z.
- Development of a novel nomogram-based online tool to predict axillary status after neoadjuvant chemotherapy in cN+ breast cancer: A multicentre study on 1,950 patients. Corsi F, Albasini S, Sorrentino L, Armatura G, Carolla C, Chiappa C, Combi F, Curcio A, Della Valle A, Ferrari G, Gasparri ML, Gentilini O, Ghilli M, Listorti C, Mancini S, Marinello P, Meani F, Mele S, Pertusati A, Roncella M, Rovera F, Sgarella A, Tazzioli G, Tognali D, Folli S. Breast. 2021 Dec;60:131-137. doi: 10.1016/j.breast.2021.09.013. Epub 2021 Oct 2.
- Safety of autologous fat grafting in breast cancer: a multicenter Italian study among 17 senonetwork breast units autologous fat grafting safety: a multicenter Italian retrospective study. Klinger M, Losurdo A, Lisa AVE, Morenghi E, Vinci V, Corsi F, Albasini S, Leonardi MC, Jereczek-Fossa BA, Veronesi P, Rietjens M, Fabiocchi L, Santicchia S, Klinger F, Loreti A, Fortunato L, Bocchiotti MA, Nicolò FA, Stringhini P, Parodi PC, Rampino E, Guarneri V, Pagura G, Venezia ED, Meneghini G, Kraljic T, Persichetti P, Barone M, Vaia N, Zerini I, Grimaldi L, Riccio M, Aquinati A, Bassetto F, Vindigni V, Ciuffreda L, Tinterri C, Santoro A. Breast Cancer Res Treat. 2022 Jan;191(2):355-363. doi: 10.1007/s10549-021-06444-9. Epub 2021 Nov 9.
- Preoperative Systemic Inflammatory Biomarkers Are Independent Predictors of Disease Recurrence in ER+ HER2- Early Breast Cancer. Truffi M, Piccotti F, Albasini S, Tibollo V, Morasso CF, Sottotetti F, Corsi F. Front Oncol. 2021 Nov 4;11:773078. doi: 10.3389/fonc.2021.773078. eCollection 2021.
- Fast quantification of extracellular vesicles levels in early breast cancer patients by Single Molecule Detection Array (SiMoA). Morasso C, Ricciardi A, Sproviero D, Truffi M, Albasini S, Piccotti F, Sottotetti F, Mollica L, Cereda C, Sorrentino L, Corsi F. Breast Cancer Res Treat. 2022 Feb;192(1):65-74. doi: 10.1007/s10549-021-06474-3. Epub 2021 Dec 21.
- Prognostic Potential of Immune Inflammatory Biomarkers in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Truffi M, Sottotetti F, Gafni N, Albasini S, Piccotti F, Morasso C, Tibollo V, Mocchi M, Zanella V, Corsi F. Cancers (Basel). 2022 Oct 27;14(21):5287. doi: 10.3390/cancers14215287. PMID: 36358706; PMCID: PMC9658892.
- Extensive Intraductal Component in Breast Cancer: What Role in Disease-Free Survival? Corsi F, Albasini S, Ciciriello S, Villani L, Truffi M, Sevieri M, Sorrentino L. J Surg Res. 2023 Mar;283:233-240. doi: 10.1016/j.jss.2022.10.094. Epub 2022 Nov 21. PMID: 36423471.
- DeepMiCa: Automatic segmentation and classification of breast MIcroCAlcifications from mammograms. Gerbasi A, Clementi G, Corsi F, Albasini S, Malovini A, Quaglini S, Bellazzi R. Comput Methods Programs Biomed. 2023 Jun;235:107483. doi: 10.1016/j.cmpb.2023.107483. Epub 2023 Mar 31. PMID: 37030174.
- Whitlockite has a characteristic distribution in mammary microcalcifications and it is not associated with breast cancer. Morasso C, Vanna R, Piccotti F, Frizzi L, Truffi M, Albasini S, Borca C, Huthwelker T, Villani L, Bunk O, Giannini C, Corsi F. Cancer Commun (Lond). 2023 Sep 9. doi: 10.1002/cac2.12481. Epub ahead of print. PMID: 37688557.
- Low neutrophil-to-lymphocyte ratio and pan-immune-inflammation-value predict nodal pathologic complete response in 1274 breast cancer patients treated with neoadjuvant chemotherapy: a multicenter analysis. Gasparri ML, Albasini S, Truffi M, Favilla K, Tagliaferri B, Piccotti F, Bossi D, Armatura G, Calcinotto A, Chiappa C, Combi F, Curcio A, Della Valle A, Ferrari G, Folli S, Ghilli M, Listorti C, Mancini S, Marinello P, Mele S, Pertusati A, Roncella M, Rossi L, Rovera F, Segattini S, Sgarella A, Tognali D, Corsi F. Ther Adv Med Oncol. 2023 Sep 15;15:17588359231193732. doi: 10.1177/17588359231193732. PMID: 37720495; PMCID: PMC10504832.
- Ultrastructural analysis of breast cancer patient-derived organoids Lorena Signati, Raffaele Allevi, Francesca Piccotti, Sara Albasini, Laura Villani, Marta Sevieri, Arianna Bonizzi, Fabio Corsi, Serena Mazzucchelli. Cancer Cell Int. 2021 Aug 10;21(1):423. doi: 10.1186/s12935-021-02135-z.
- Development of a novel nomogram-based online tool to predict axillary status after neoadjuvant chemotherapy in cN+ breast cancer: A multicentre study on 1,950 patients. Corsi F, Albasini S, Sorrentino L, Armatura G, Carolla C, Chiappa C, Combi F, Curcio A, Della Valle A, Ferrari G, Gasparri ML, Gentilini O, Ghilli M, Listorti C, Mancini S, Marinello P, Meani F, Mele S, Pertusati A, Roncella M, Rovera F, Sgarella A, Tazzioli G, Tognali D, Folli S. Breast. 2021 Dec;60:131-137. doi: 10.1016/j.breast.2021.09.013. Epub 2021 Oct 2.
- Safety of autologous fat grafting in breast cancer: a multicenter Italian study among 17 senonetwork breast units autologous fat grafting safety: a multicenter Italian retrospective study. Klinger M, Losurdo A, Lisa AVE, Morenghi E, Vinci V, Corsi F, Albasini S, Leonardi MC, Jereczek-Fossa BA, Veronesi P, Rietjens M, Fabiocchi L, Santicchia S, Klinger F, Loreti A, Fortunato L, Bocchiotti MA, Nicolò FA, Stringhini P, Parodi PC, Rampino E, Guarneri V, Pagura G, Venezia ED, Meneghini G, Kraljic T, Persichetti P, Barone M, Vaia N, Zerini I, Grimaldi L, Riccio M, Aquinati A, Bassetto F, Vindigni V, Ciuffreda L, Tinterri C, Santoro A. Breast Cancer Res Treat. 2022 Jan;191(2):355-363. doi: 10.1007/s10549-021-06444-9. Epub 2021 Nov 9.
- Preoperative Systemic Inflammatory Biomarkers Are Independent Predictors of Disease Recurrence in ER+ HER2- Early Breast Cancer. Truffi M, Piccotti F, Albasini S, Tibollo V, Morasso CF, Sottotetti F, Corsi F. Front Oncol. 2021 Nov 4;11:773078. doi: 10.3389/fonc.2021.773078. eCollection 2021.
- Fast quantification of extracellular vesicles levels in early breast cancer patients by Single Molecule Detection Array (SiMoA). Morasso C, Ricciardi A, Sproviero D, Truffi M, Albasini S, Piccotti F, Sottotetti F, Mollica L, Cereda C, Sorrentino L, Corsi F. Breast Cancer Res Treat. 2022 Feb;192(1):65-74. doi: 10.1007/s10549-021-06474-3. Epub 2021 Dec 21.
- Prognostic Potential of Immune Inflammatory Biomarkers in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Truffi M, Sottotetti F, Gafni N, Albasini S, Piccotti F, Morasso C, Tibollo V, Mocchi M, Zanella V, Corsi F. Cancers (Basel). 2022 Oct 27;14(21):5287. doi: 10.3390/cancers14215287. PMID: 36358706; PMCID: PMC9658892.
- Extensive Intraductal Component in Breast Cancer: What Role in Disease-Free Survival? Corsi F, Albasini S, Ciciriello S, Villani L, Truffi M, Sevieri M, Sorrentino L. J Surg Res. 2023 Mar;283:233-240. doi: 10.1016/j.jss.2022.10.094. Epub 2022 Nov 21. PMID: 36423471.
- DeepMiCa: Automatic segmentation and classification of breast MIcroCAlcifications from mammograms. Gerbasi A, Clementi G, Corsi F, Albasini S, Malovini A, Quaglini S, Bellazzi R. Comput Methods Programs Biomed. 2023 Jun;235:107483. doi: 10.1016/j.cmpb.2023.107483. Epub 2023 Mar 31. PMID: 37030174.
- Whitlockite has a characteristic distribution in mammary microcalcifications and it is not associated with breast cancer. Morasso C, Vanna R, Piccotti F, Frizzi L, Truffi M, Albasini S, Borca C, Huthwelker T, Villani L, Bunk O, Giannini C, Corsi F. Cancer Commun (Lond). 2023 Sep 9. doi: 10.1002/cac2.12481. Epub ahead of print. PMID: 37688557.
- Low neutrophil-to-lymphocyte ratio and pan-immune-inflammation-value predict nodal pathologic complete response in 1274 breast cancer patients treated with neoadjuvant chemotherapy: a multicenter analysis. Gasparri ML, Albasini S, Truffi M, Favilla K, Tagliaferri B, Piccotti F, Bossi D, Armatura G, Calcinotto A, Chiappa C, Combi F, Curcio A, Della Valle A, Ferrari G, Folli S, Ghilli M, Listorti C, Mancini S, Marinello P, Mele S, Pertusati A, Roncella M, Rossi L, Rovera F, Segattini S, Sgarella A, Tognali D, Corsi F. Ther Adv Med Oncol. 2023 Sep 15;15:17588359231193732. doi: 10.1177/17588359231193732. PMID: 37720495; PMCID: PMC10504832.
Comprimi
Vedi il profilo
Scarica il CV
Laboratori di ricerca
Laboratorio di nanomedicina e imaging molecolare